Skip to main content
Clinical Trials/IRCT20150101020514N13
IRCT20150101020514N13
Recruiting
Phase 2

Safety and efficacy comparison of gel and emulgel formulations of tretinoin 0.025% and clindamaycin 1.2% for treatment of mild to moderate acne vulgaris

Jarf Andishan Nnavid Salamat knowlage based company (JANUS)0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Acne vulgaris.
Sponsor
Jarf Andishan Nnavid Salamat knowlage based company (JANUS)
Enrollment
20
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Jarf Andishan Nnavid Salamat knowlage based company (JANUS)

Eligibility Criteria

Inclusion Criteria

  • Male or female aged 16\-40 years
  • Mild to moderate inflammatory or non\-inflammatory acne lesions (grade 1 to 3 according to the table) on face

Exclusion Criteria

  • People with allergies to formulation ingredients
  • Nodular or cystic lesions that represent a severe type of acne vulgaris

Outcomes

Primary Outcomes

Not specified

Similar Trials